Survivorship and post-treatment health and wellbeing in women following treatment for endometrial cancer. Cancer
Conditions
Interventions
Participants enrolled in the study will take part in OurPERSPECTIVE
a structured survivorship programme designed for women who completed primary treatment for endometrial cancer at least 36 months prior to enrolment. Following consent and baseline assessment, particip
Sponsors
University Hospitals of Leicester NHS Trust
Eligibility
Sex/Gender
Female
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Adult women (aged =18 years) 2. Histologically confirmed endometrial cancer, treated with curative intent 3. Completed primary treatment (surgery with or without adjuvant radiotherapy and or chemotherapy) 4. Cancer-free and not receiving active anti-cancer treatment at enrolment (excluding maintenance or non-cancer medications) 5. At the survivorship timepoint: 36 months post treatment completion (preferred, consistent with OurPERSPECTIVE specification) 6. Able to provide informed consent 7. Able to participate in the intervention delivery mode (for example, online): access to an internet-enabled device and sufficient digital literacy to engage with materials (with reasonable support as planned) 8. Able to understand study materials in English (or the languages provided, if translated versions are available)
Exclusion criteria
Exclusion criteria: 1. Evidence of recurrent or metastatic endometrial cancer, or undergoing investigation for suspected recurrence at enrolment 2. Currently receiving active anti-cancer treatment for endometrial cancer (for example, chemotherapy, radiotherapy, immunotherapy, targeted therapy), excluding routine surveillance follow-up 3. Less than 36 months since completion of primary endometrial cancer treatment 4. Unable to provide informed consent 5. Insufficient proficiency in the language(s) of the intervention materials to participate meaningfully (unless translated materials and support are available) 6. Severe cognitive impairment or severe mental health presentation that, in the judgement of the clinical or research team, would prevent safe and informed participation (for example, acute psychosis, severe unmanaged depression with marked functional impairment) 7. Medical instability or intercurrent illness that would make participation unsafe or impracticable during the intervention period (for example, current hospital admission, uncontrolled symptoms requiring urgent escalation) 8. Concurrent enrolment in another structured survivorship intervention trial that would materially confound outcomes (case-by-case judgement; observational studies usually permitted) 9. Practical inability to participate in the intervention delivery mode (for example, no access to the necessary device or internet for a digital programme, where no alternative access pathway is provided)
Countries
England, United Kingdom
Contacts
Public ContactEsther Moss
Outcome results
None listed